161 related articles for article (PubMed ID: 37938527)
1. The prognostic value of 4L lymph node dissection in left-side operable non-small-cell lung cancer: a meta-analysis.
Peng L; Huang KL; Shang QW; Wang Y; Li W
Updates Surg; 2024 Jan; 76(1):23-32. PubMed ID: 37938527
[TBL] [Abstract][Full Text] [Related]
2. Dissection of 4L lymph node for left-sided non-small cell lung cancer: a meta-analysis.
Deng HY; Li D; Qiu XM; Zhu DX; Tang X; Zhou Q
ANZ J Surg; 2021 Nov; 91(11):E696-E702. PubMed ID: 34405519
[TBL] [Abstract][Full Text] [Related]
3. The impact of station 4L lymph node dissection on short-term and long-term outcomes in non-small cell lung cancer.
Wo Y; Li H; Zhang Y; Peng Y; Wu Z; Liu P; Shang Y; Hu H; Zhang Y; Xiang J; Sun Y
Lung Cancer; 2022 Aug; 170():141-147. PubMed ID: 35780588
[TBL] [Abstract][Full Text] [Related]
4. Impact of L4 lymph node dissection on long-term survival in left-side operable non-small-cell lung cancer: a propensity score matching study.
Yang MZ; Hou X; Li JB; Cai JS; Yang J; Li S; Long H; Fu JH; Zhang LJ; Lin P; Rong TH; Yang HX
Eur J Cardiothorac Surg; 2020 Jun; 57(6):1181-1188. PubMed ID: 32016340
[TBL] [Abstract][Full Text] [Related]
5. Station 3A lymph node dissection does not improve long-term survival in right-side operable non-small-cell lung cancer patients: A propensity score matching study.
Yang MZ; Tan ZH; Li JB; Long H; Fu JH; Zhang LJ; Lin P; Hou X; Yang HX
Thorac Cancer; 2022 Aug; 13(15):2106-2116. PubMed ID: 35702992
[TBL] [Abstract][Full Text] [Related]
6. Predictors and survival impact of station 4L metastasis in left non-small cell lung cancer.
Fang L; Wang L; Wang Y; Wu Y; Ye P; Lv W; Hu J
J Cancer Res Clin Oncol; 2019 May; 145(5):1313-1319. PubMed ID: 30877377
[TBL] [Abstract][Full Text] [Related]
7. Lobe-specific nodal dissection with intraoperative frozen section analysis for clinical stage-I non-small cell lung cancer: a validation study by propensity score matching.
Isaka M; Kojima H; Imai T; Konno H; Mizuno T; Nagata T; Katsumata S; Kawata T; Nakajima T; Ohde Y
Gen Thorac Cardiovasc Surg; 2022 Nov; 70(11):977-984. PubMed ID: 35543932
[TBL] [Abstract][Full Text] [Related]
8. Survival Benefit of Left Lower Paratracheal (4L) Lymph Node Dissection for Patients with Left-Sided Non-small Cell Lung Cancer: Once Neglected But of Great Importance.
Zhao K; Wei S; Mei J; Guo C; Hai Y; Chen N; Liu L
Ann Surg Oncol; 2019 Jul; 26(7):2044-2052. PubMed ID: 31011902
[TBL] [Abstract][Full Text] [Related]
9. Clinical Significance of 4L Lymph Node Dissection in Left Lung Cancer.
Wang YN; Yao S; Wang CL; Li MS; Sun LN; Yan QN; Tang SW; Zhang ZF
J Clin Oncol; 2018 Oct; 36(29):2935-2942. PubMed ID: 30148659
[TBL] [Abstract][Full Text] [Related]
10. The impact of left lower paratracheal (4L) lymph node dissection on survival in patients with surgically treated left-sided NSCLC.
Gryszko GM; Cackowski MM; Zbytniewski M; Woźnica K; Orłowski TM; Dziedzic DA;
Eur J Cardiothorac Surg; 2021 Nov; 60(5):1201-1209. PubMed ID: 34279610
[TBL] [Abstract][Full Text] [Related]
11. Adequate lymph node dissection is essential for accurate nodal staging in intrahepatic cholangiocarcinoma: A population-based study.
Zhu J; Liu C; Li H; Ren H; Cai Y; Lan T; Wu H
Cancer Med; 2023 Apr; 12(7):8184-8198. PubMed ID: 36645113
[TBL] [Abstract][Full Text] [Related]
12. Clinical Benefits of Lobe-Specific Lymph Node Dissection in Surgery for NSCLC: A Systematic Review and Meta-Analysis.
Woo W; Shin JI; Kipkorir V; Yang YH; Lee S; Lee CY
JTO Clin Res Rep; 2023 May; 4(5):100516. PubMed ID: 37214413
[TBL] [Abstract][Full Text] [Related]
13. Systematic Versus Lobe-Specific Mediastinal Lymphadenectomy for Hypermetabolic Lung Cancer.
Handa Y; Tsutani Y; Mimae T; Miyata Y; Ito H; Shimada Y; Nakayama H; Ikeda N; Okada M
Ann Surg Oncol; 2021 Nov; 28(12):7162-7171. PubMed ID: 34218364
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological and survival outcomes of 4L lymph node dissection in left lung adenocarcinoma and squamous cell carcinoma.
Shen L; Guo J; Zhang W; Liang C; Chen H; Liu Y
Front Oncol; 2023; 13():1124014. PubMed ID: 37114135
[TBL] [Abstract][Full Text] [Related]
15. D3 Lymph Node Dissection Improves Survival Outcomes in Patients With cT2 Colorectal Non-well-differentiated Adenocarcinoma.
Wang L; Song B; Chen Y; Hirano Y
In Vivo; 2024; 38(2):807-818. PubMed ID: 38418105
[TBL] [Abstract][Full Text] [Related]
16. Clinical Significance of Station 3A Lymph Node Dissection in Patients with Right-Side Non-Small-Cell Lung Cancer: A Retrospective Propensity-Matched Analysis.
Liu C; Wei S; Guo C; Mei J; Pu Q; Liu L
Ann Surg Oncol; 2021 Jan; 28(1):194-202. PubMed ID: 32638165
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic effect of mediastinal lymph node dissection in patients with stage I non-small cell lung cancer].
Su XD; Wang X; Rong TH; Long H; Fu JH; Lin P; Zhang LJ; Wang SY; Wen ZS; Ma GW
Zhonghua Wai Ke Za Zhi; 2007 Nov; 45(22):1543-5. PubMed ID: 18282391
[TBL] [Abstract][Full Text] [Related]
18. The Significance of Lymph Node Ratio and Total Lymph Nodes Examined in Determining the Indications of Adjuvant Radiation in pN2 Non-small Cell Lung Cancer.
Zhu F; Wang H; Ashamalla H
Clin Lung Cancer; 2022 Sep; 23(6):e384-e393. PubMed ID: 35676168
[TBL] [Abstract][Full Text] [Related]
19. Completeness of lymph node dissection in patients undergoing minimally invasive- or open surgery for non-small cell lung cancer: A nationwide study.
van der Woude L; Wouters MWJM; Hartemink KJ; Heineman DJ; Verhagen AFTM
Eur J Surg Oncol; 2021 Jul; 47(7):1784-1790. PubMed ID: 33223414
[TBL] [Abstract][Full Text] [Related]
20. Value of lymph node dissection in intrahepatic cholangiocarcinoma: a systematic review and meta-analysis.
Yeow M; Fong KY; Zhao JJ; Tan AYH; Koh YX; Kam JH; Goh BKP; Pawlik TM; Kabir T
HPB (Oxford); 2024 Feb; 26(2):161-170. PubMed ID: 38071187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
